Construction and Anti-tumor Effect Evaluation of a Dual-Responsive Hyaluronic Acid Carbon Quantum Dot-Gelatin Nano-Drug Delivery System

LI Man, LI Jian-ping, WANG Ya-shi, HE Qin

Abstract

To construct a pH and matrix metalloproteinase (MMP) dual-responsive nano drug delivery system with adjustable particle size so as to synergistically enhance the retention and penetration of chemotherapeutic drugs in tumor tissues and improve tumor treatment effect.  Methods  Hyaluronic acid (HA) carbon quantum dots (CD) coupled with gelatin nanoparticle (GNP) were constructed, and were connected with doxorubicin (DOX), a chemotherapeutic drug, through pH-sensitive imine to produce GNP@HA-CD-DOX nanoparticles. The changes of particle size, drug release behavior, hemocompatibility, cell uptake and deep penetration of tumor spheroids, in vivo tumor targeting and therapeutic effect were analyzed.  Results  GNP@HA-CD-DOX nanoparticles had a particle size of (162.93±2.55) nm, which could be degraded to release HA-CD-DOX with a particle size of about 40 nm under the treatment of MMP. The drug loading of DOX was (4.94±0.22)%. DOX was released in the tumor microenvironment and lysosomes in response to the low pH. No obvious hemolysis was observed in GNP@HA-CD-DOX. GNP@HA-CD-DOX showed a reduction in particle size after co-incubation with MMP-2. The MMP-sensitive GNP@HA-CD-DOX had significantly improved cell uptake and better deep penetration in tumor spheres. GNP@HA-CD-DOX displayed better distribution in tumor and anti-tumor ability in tumor-bearing mice compared with the small particle size HA-CD-DOX group. In addition, it has better safety.  Conclusion  The pH and MMP dual-sensitive nano-tech drug delivery system with adjustable particle sizes synergistically enhances the retention and deep penetration of drugs in tumors as well as the anti-tumor effect, suggesting new approaches to tumor treatment.

 

Keywords: Matrix metalloproteinase, Adjustable particle size, Gelatin nanoparticle, Carbon quantum dots, Doxorubicin

 

Full Text:

PDF


References


ZHOU Q， DONG C， FAN W， et al. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy. Biomaterials， 2020， 240: 119902[2020-02-18]. https://doi.org/10.1016/j.biomaterials.2020.119902.

LI Z， XIAO C， YONG T， et al. Influence of nanomedicine mechanical properties on tumor targeting delivery. Chem Soc Rev，2020，49(8): 2273–2290.

OJHA T， PATHANK V， SHI Y， et al. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. Adv Drug Deliv Rev，2017，119: 44–60.

SUN Q， OJHA T， KIESSLING F， et al. Enhancing Tumor Penetration of Nanomedicines. Biomacromolecules，2017，18(5): 1449–1459.

WANG J， MAO W， LOCK L L， et al. The role of micelle size in tumor accumulation, penetration, and treatment. ACS Nano，2015，9(7): 7195–7206.

PARK H， SARAVANAKUMAR G， KIM J， et al. Tumor microenvironment sensitive nanocarriers for bioimaging and therapeutics. Adv Healthc Mater， 2021， 10(5): e2000834[2020-10-19]. https://doi.org/10.1002/adhm.202000834.

HE Q， CHEN J， YAN J， et al. Tumor microenvironment responsive drug delivery systems. Asian J Pharm Sci，2020，15(4): 416–448.

JIA N， LI W， LIU D， et al. Tumor microenvironment stimuli-responsive nanoparticles for programmed anticancer drug delivery. Mol Pharm， 2020，17(5): 1516–1526.

CUN X， CHEN J， RUAN S， et al. A Novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration. ACS Appl Mater Interfaces， 2015，7(49): 27458–27466.

CUN X， LI M， WANG S， et al. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration. Nanoscale，2018，10(21): 9935–9948.

PANWAR N， SOEHARTONO A M， CHAN K K， et al. Nanocarbons for biology and medicine: Sensing, imaging, and drug delivery. Chem Rev，2019，119(16): 9559–9656.

DU J， XU N， FAN J， et al. Carbon dots for in vivo bioimaging and theranostics. Small， 2019， 15(32): e1805087[2019-12-18]. https://doi.org/10.1002/smll.201805087.

LI J， LI M， TIAN L， et al. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy. Int J Pharm， 2020， 578， 119122[2020-02-05]. https://doi.org/10.1016/j.ijpharm.2020.119122.

KAEMMERER E， MELCHELS F P W， HOLZAPFEL B M， et al. Gelatine methacrylamide-based hydrogels: An alternative three-dimensional cancer cell culture system. Acta Biomaterialia，2014，10(6): 2551–2562.

COX T R. The matrix in cancer. Nat Rev Cancer，2021，21(4): 217–238.

CABRAL H， MATSUMOTO Y， MIZUNO K， et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol，2011，6(12): 815–823.

YAO Q， KOU L， TU Y， et al. MMP-responsive ‘Smart’ drug delivery and tumor targeting. Trends Pharmacol Sci，2018，39(8): 766–781.

EGEBLAD M， WERB Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer，2002，2(3): 161–174.


Refbacks

  • There are currently no refbacks.